The analysis of global hospital average length of stay for leiomyoma of the uterus in 2024 shows Sweden with the shortest stay at 1.8 days, while Bulgaria has the longest at 4.9 days. In 2023, most countries experienced a decrease in the average length of stay, with France showing the most significant reduction of 5.22%. Other notable decreases include Latvia at 4.14% and Hungary at 3.68%, indicating improved efficiency in handling these cases. The year-over-year percentage decrease highlights a trend toward shorter hospitalizations, likely due to advances in medical procedures and postoperative care.
Future trends to watch for include continued enhancements in minimally invasive surgical techniques and preoperative care, which could further reduce hospital stays for leiomyoma of the uterus. Monitoring these advancements will be crucial in understanding their impact on healthcare system efficiencies globally.
Top countries in Hospital Average Length of Stay for Leiomyoma of Uterus by Country
| # | 7 Countries | Days | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Bulgaria | 4.9 | 2021 | View data | ||
| 2 | 2 South Korea | 3.6 | 2023 | -2.7% | -2.57% | View data |
| 3 | 3 Latvia | 3.4 | 2023 | -2.86% | -4.14% | View data |
| 4 | 4 Hungary | 3.4 | 2023 | -2.86% | -3.68% | View data |
| 5 | 5 Spain | 2.9 | 2023 | -3.33% | -3.13% | View data |
| 6 | 6 France | 2.6 | 2023 | -7.14% | -5.22% | View data |
| 7 | 7 Sweden | 1.8 | 2023 | 0% | -1.08% | View data |
